Jason Mendy
Director at Emergent BioSolutions- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Emergent BioSolutions
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Director
-
Nov 2018 - Present
-
-
-
PaxVax, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Director
-
Feb 2017 - Oct 2018
Head of Translational R&D Immunology division responsible for pre-clinical and clinal assay development supporting vaccine development and clinical trials for Chikungunya, Zika, Adenovirus, and HIV vaccines. Study Director of Clinical Immunology team responsible for testing clinical serum samples in a GCLP compliant laboratory using luciferase-based virus neutralization assays determine antibody titers to Chikungunya, Adenovirus, and Zika. Focus on qualification and validation of automated high-throughput assays.
-
-
-
MediVas
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Scientist
-
Nov 2007 - Feb 2017
Immunologist developing replication competent adenovirus based vectored vaccines against infectious diseases such as H5N1 influenza, HIV-1, and anthrax specializing in pre-clinical animal models and pre-clinical and clinical assay development. Immunologist developing replication competent adenovirus based vectored vaccines against infectious diseases such as H5N1 influenza, HIV-1, and anthrax specializing in pre-clinical animal models and pre-clinical and clinical assay development.
-
-
-
MediVas
-
Biotechnology Research
-
1 - 100 Employee
-
Staff Scientist
-
2004 - 2007
Immunologist developing synthetic biodegradable polymer based vaccines against infectious diseases such as H5N1 influenza and HPV. Immunologist developing synthetic biodegradable polymer based vaccines against infectious diseases such as H5N1 influenza and HPV.
-
-
-
-
Senior Research Associate
-
2001 - 2004
Studies focused on developing a unique mucosal vaccine delivery technology based on receptor specific targeting of M-cells in the gastrointestinal mucosa and nasal associated epithelium Studies focused on developing a unique mucosal vaccine delivery technology based on receptor specific targeting of M-cells in the gastrointestinal mucosa and nasal associated epithelium
-
-
-
Celgene
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Associate II
-
1997 - 2001
Participated in multiple projects including Gene Discovery, Target Biology, Functional Genomics and Bioinformatics with focus on brain and breast cancer oncology. Participated in multiple projects including Gene Discovery, Target Biology, Functional Genomics and Bioinformatics with focus on brain and breast cancer oncology.
-
-
Education
-
San Diego State University-California State University
Master's degree, Cell/Cellular and Molecular Biology -
Adrian Wilcox High School